The company is in advanced stages of negotiations with a UPS manufacturer each in Europe and China and the deal may come through within a few months, said Mithun Chittilappalli, executive director, V-Guard. At present, the company manufactures only online UPS, targeted at domestic users of computers and electronic gadgets, which contribute only 5-6 per cent to its around Rs 300-crore (Rs 3-billion) turnover.
Within months of charging the moon, Indian real estate firms are now offering buy-back of properties, free cars and even free apartments to tide over the current slump which has seen sales halve from the beginning of the year.
MSD Pharmaceuticals, the wholly-owned subsidiary of US-based multinational drug company Merck, has chartered an ambitious growth plan to emerge as one of the top five pharmaceutical companies in India. The Merck subsidiary has plans to step up its research and clinical trial programmes in India, mainly in association with hospitals and universities.
At a time when most retail firms have either gone slow in opening new stores or closed down some to beat the ongoing slump, the Future Group has opened nearly 150 stores across all its formats over the past three months. This month alone, Biyani is opening 15 stores, mainly selling electronic and lifestyle goods.
Anil Ambani-promoted Reliance Power (R-Power) has signed a supplementary power purchase agreement (PPA) with fourteen buyers from seven states for its upcoming 4,000-MW ultra mega power project (UMPP) in Sasan.
The JV was expected to open 56 exclusive high-end stores for the four focus brands, Miss Sixty, Energie, Killah & Murphy&Nye, in the top 10 cities in the first three years. As per the original plans, Darshan Mehta president and chief executive of Reliance Brands, was to spearhead the JV with separate business heads for each of the four brands.
Karl-Ludwig Kley, chairman of the executive board, Merck, spoke to Business Standard about the company's plans and how it is weathering the global financial crisis.
Last year, Trent had entered into a tie-up with The Xander Group wherein Xander was to invest in malls along with local developers and Trent was to be the anchor tenant. Currently, three-to-four such malls are being developed in cities such as Surat and Ahmedabad.
The land development arm of the railways has cut the reserve price for a 45,371 square metre plot at Bandra, a Mumbai suburb, by nearly 14.5 per cent, to Rs 39.60 billion and reduced the minimum networth requirement for bidders by a similar margin. It has also reduced the bid security amount by 20 per cent. This apart, the authority has more than doubled the payment period to five years.
Stringent regulatory norms and the financial impact of the global credit crisis on some research companies may hurt half a dozen molecules of Indian companies, such as Glenmark, Nicholas Piramal and Ranbaxy Laboratories, that are close to launch, experts and analysts said.
Most realtors are already advertising cash discounts of 5-10 per cent on upfront payment and buyers can get up to 25 per cent discount if they book properties and are willing to wait for two to three years until possession. According to consultants, developers may even give 15-20 per cent discount on the price as they are eager to clear inventories.
Despite a slowdown in property sales, realty developers across the country are launching new residential apartments during the ongoing Navratri festival in the hope that they will get higher sales from prospective home buyers, who have deferred their buys so far.
Brandhouse manages exclusive stores of four SKNL brands -- Reid & Taylor, Stephens Brothers, Belmonte, and Carmichael House -- and two foreign brands Dunhill and Escada. It has more than 600 stores now. The company plans to set up its first private label store early next year and the average size of the store will range from 8,000 to 10,000 sq ft, said Tarun Joshi, managing director of Brandhouse Retails, the retail unit of S Kumars Nationwide.
Analysts say prices may stagnate or decline in the next three months. Almost 70 per cent of the brokers who participated in the poll believe prices will be flat or negative in the period and even Diwali is unlikely to lift the mood in the property market.
Citec Engineering India, which employs half of Citec's global workforce, is planning to increase its headcount in India from 255 to over 350 by the end of this year, said Martin Strand, CEO, Citec. "We hope to become a significant player in India in the engineering services for power, oil and gas industry, considering the development in the sector. We target to double our Indian business within two years," he said.
Real estate companies such as Unitech, Peninsula Land, HDIL and Future Capital, the financial services arm of Future Group, are in talks with investors including some leading private equity funds for raising investments for their projects, after the collapse of Lehman Brothers, whose third party fund had promised investments in these property companies' projects, according to industry sources.
The company has already received an approval to spend Rs 50,000 crore (Rs 500 billion) for commercialising two of its biggest gas discoveries in the D6 block located in the KG basin. "In a letter to oil regulator Directorate General of Hydrocarbons, the company has submitted one more development plan for Rs 10,000 crore as additional capex (capital expenditure) for the block.
ADAG has drawn up plans to invest Rs 650 billion in the steel, cement and shipping se three new areas over the next five years. The investment includes Rs 200 billion to set-up a 10 million cement plant and Rs 400 billion towards a steel plant in Jharkhand. The group believes that the three new lines of businesses fit more with RNRL than with other companies under the group, an ADAG source said.
Piramal Life Sciences may become the first company to successfully develop a tuberculosis drug whose leads isolated from the living organisms found in ice brought from the Antarctica region. "(Our) scientists have identified additional leads that will help develop drugs to treat tuberculosis and other infections," revealed Swati Piramal, director, Nicholas Piramal.
ABRPL is working on developing drugs for anaemia, cancer and arthritis, said Bruce Murdoch, chief business officer, Avesthagen. "We are targeting high-end products that are going off-patent and are not working on popular soon-to-be off-patent biotech molecules. We should be able to bring a couple of molecules into the commercialisation stage next year," he said.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances